Back to HomeBeta

ICD-10 Coding for Lung Cancer with Metastasis(C34.90, C78.00)

Complete ICD-10-CM coding and documentation guide for Lung Cancer with Metastasis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic Lung CancerSecondary Lung Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Lung Cancer with Metastasis

C34Primary Range

Malignant neoplasm of bronchus and lung

Primary code range for lung cancer, specifying the site and laterality.

Secondary malignant neoplasm of lung

Used when lung is a secondary site of metastasis.

Secondary malignant neoplasm of other sites

Used for metastasis to sites other than lung.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C34.90Malignant neoplasm of unspecified part of bronchus or lungUse when the specific site of the lung cancer is not documented.
  • Imaging showing lung mass
  • Biopsy confirming malignancy
C78.00Secondary malignant neoplasm of unspecified lungUse when lung is a secondary site and specific lung site is not documented.
  • Imaging showing lung involvement
  • History of primary cancer elsewhere

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: How do you code lung cancer with metastasis?

Essential facts and insights about Lung Cancer with Metastasis

Code primary lung cancer with C34.x and use C78.0x for secondary lung metastasis. Sequence based on treatment focus.

Primary ICD-10-CM Codes for lung cancer with metastasis

Malignant neoplasm of unspecified part of bronchus or lung
Billable Code

Decision Criteria

documentation Criteria

  • Specific site and laterality are not documented.

Applicable To

  • Lung cancer NOS

Excludes

  • Benign neoplasm of bronchus and lung (D14.3)

Clinical Validation Requirements

  • Imaging showing lung mass
  • Biopsy confirming malignancy

Code-Specific Risks

  • Lack of specificity may affect treatment decisions.

Coding Notes

  • Ensure documentation specifies if the cancer is primary or secondary.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use when the patient is receiving chemotherapy.

Personal history of other malignant neoplasm of bronchus and lung

Z85.118
Use if the primary lung cancer is in remission.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of upper lobe, unspecified bronchus or lung

C34.10
Use when the upper lobe is specified but laterality is not.

Primary lung cancer

C34.90
Differentiate based on primary vs. secondary site documentation.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Lung Cancer with Metastasis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.90.

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement due to lack of specificity.

Mitigation Strategy

Review documentation for specific site details., Educate providers on importance of specificity.

Impact

Reimbursement: Incorrect sequencing can affect DRG assignment and reimbursement., Compliance: May lead to non-compliance with coding guidelines., Data Quality: Affects accuracy of patient records and data reporting.

Mitigation Strategy

Sequence based on treatment focus: secondary first if treatment is directed at metastasis.

Impact

Sequencing errors in primary vs. secondary neoplasm coding.

Mitigation Strategy

Regular training on sequencing rules and documentation review.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Lung Cancer with Metastasis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Lung Cancer with Metastasis

Use these documentation templates to ensure complete and accurate documentation for Lung Cancer with Metastasis. These templates include all required elements for proper coding and billing.

Lung cancer with bone metastasis

Specialty: Oncology

Required Elements

  • Primary site documentation
  • Metastatic site documentation
  • Treatment plan

Example Documentation

Patient with NSCLC of left upper lobe (C34.12) with metastasis to lumbar spine (C79.51).

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lung cancer with bone involvement.
Good Documentation Example
Metastatic adenocarcinoma from left upper lobe to lumbar spine.
Explanation
Specifies primary and metastatic sites, improving clarity and coding accuracy.

Need help with ICD-10 coding for Lung Cancer with Metastasis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more